Followers | 257 |
Posts | 29702 |
Boards Moderated | 0 |
Alias Born | 08/26/2015 |

Monday, June 23, 2025 1:04:20 PM
So a billion shares for $160,000 by decreasing share value by 50% I question why that makes sense for any company.
Even Steve Jobs got questions for all kinds of things yet it's always shareholders who don't get it.
The minute the Reg A came out I told Marshall we will go to almost zero. He laughed at me and said it would be great for the company and said I didn't know what I was talking about.
🤷🤷. Who knows what comes in the future here. But we are at all time lows and almost zero which clearly demonstrates whatever has transpired has not worked for us that's for sure
Recent MDCE News
- Form 253G2 - • Edgar (US Regulatory) • 07/03/2025 09:12:35 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 04/14/2025 04:15:07 AM
- Form 1-A POS - • Edgar (US Regulatory) • 03/27/2025 09:27:18 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/14/2025 08:58:44 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/03/2025 10:20:18 PM
- Form 253G1 - • Edgar (US Regulatory) • 12/06/2024 07:42:43 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 11/26/2024 09:09:28 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 09/06/2024 05:46:30 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 08/09/2024 07:33:41 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM